Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 175

1.

Behçet syndrome: effects of Pycnogenol® supplementation during regression phases.

Hu S, Belcaro G, Ledda A, Corsi M, Cotellese R, Feragalli B, Hosoi M, Dugall M, Torino-Rodriguez P, Cesarone MR.

Minerva Cardioangiol. 2018 Aug;66(4):386-390. doi: 10.23736/S0026-4725.18.04637-6.

PMID:
29975020
2.

Benign prostatic hypertrophy: Pycnogenol® supplementation improves prostate symptoms and residual bladder volume.

Ledda A, Belcaro G, Feragalli B, Cornelli U, Dugall M, Corsi M, Cesarone MR.

Minerva Med. 2018 Aug;109(4):280-284. doi: 10.23736/S0026-4806.18.05572-6.

PMID:
29947491
3.

Prevention of recurrent venous thrombosis and post-thrombotic syndrome.

Belcaro G, Dugall M, Hu S, Feragalli B, Cotellese R, Ledda A, Corsi M, Ricci A, Ippolito E, Errichi BM, Cornelli U, Cesarone MR, Hosoi M.

Minerva Cardioangiol. 2018 Jun;66(3):238-245. doi: 10.23736/S0026-4725.18.04618-2.

PMID:
29795059
4.

Temporary kidney dysfunction: Robuvit® supplementation in initial, transient kidney insufficiency and micro-macro albuminuria.

Ledda A, Belcaro G, Feragalli B, Hosoi M, Cacchio M, Luzzi R, Dugall M, Cotellese R, Cesarone MR.

Panminerva Med. 2018 Jun;60(2):60-64. doi: 10.23736/S0031-0808.18.03420-1.

5.

Left Ventricular Diastolic Dysfunction in β-Thalassemia Major with Heart Failure.

Mancuso L, Vitrano A, Mancuso A, Sacco M, Ledda A, Maggio A.

Hemoglobin. 2018 Jan;42(1):68-71. doi: 10.1080/03630269.2018.1451341.

PMID:
29633668
6.

Centella asiatica (Centellicum®) facilitates the regular healing of surgical scars in subjects at high risk of keloids.

Cotellese R, Hu S, Belcaro G, Ledda A, Feragalli B, Dugall M, Hosoi M, Ippolito E.

Minerva Chir. 2018 Apr;73(2):151-156. doi: 10.23736/S0026-4733.18.07666-6.

PMID:
29623705
7.

Testicular development in male lambs prenatally exposed to a high-starch diet.

Mossa F, Bebbere D, Ledda A, Burrai GP, Chebli I, Antuofermo E, Ledda S, Cannas A, Fancello F, Atzori AS.

Mol Reprod Dev. 2018 May;85(5):406-416. doi: 10.1002/mrd.22974. Epub 2018 Mar 30.

PMID:
29542837
8.

Phytoproflex®: supplementary management of osteoarthrosis: a supplement registry.

Belcaro G, Dugall M, Luzzi R, Hosoi M, Ledda A, Feragalli B, Hu S, Ganguly A, Eggenhoffner R, Corti A, Giacomelli L.

Minerva Med. 2018 Apr;109(2):88-94. doi: 10.23736/S0026-4806.17.05460-X.

9.

A natural pharma standard supplement formulation to control treatment-related toxicity and oxidative stress in genitourinary cancer: a preliminary study.

Ledda A, Belcaro G, Dugall M, Luzzi R, Hosoi M, Feragalli B, Cotellese R, Cosentino V, Cosentino M, Eggenhoffner R, Pellizzato M, Fratter A, Giacomelli L.

Eur Rev Med Pharmacol Sci. 2017 Sep;21(18):4196-4202.

10.

Management of Varicose Veins and Chronic Venous Insufficiency in a Comparative Registry with Nine Venoactive Products in Comparison with Stockings.

Belcaro G, Dugall M, Luzzi R, Corsi M, Ledda A, Ricci A, Pellegrini L, Cesarone MR, Hosoi M, Errichi BM, Cornelli U, Cotellese R, Agus G, Feragalli B.

Int J Angiol. 2017 Sep;26(3):170-178. doi: 10.1055/s-0036-1597756. Epub 2016 Dec 28.

PMID:
28804235
11.

Consensus Document of the Italian Association of Hospital Cardiologists (ANMCO), Italian Society of Cardiology (SIC), Italian Association of Interventional Cardiology (SICI-GISE) and Italian Society of Cardiac Surgery (SICCH): clinical approach to pharmacologic pre-treatment for patients undergoing myocardial revascularization procedures.

Caporale R, Geraci G, Gulizia MM, Borzi M, Colivicchi F, Menozzi A, Musumeci G, Scherillo M, Ledda A, Tarantini G, Gerometta P, Casolo G, Formigli D, Romeo F, Di Bartolomeo R.

Eur Heart J Suppl. 2017 May;19(Suppl D):D151-D162. doi: 10.1093/eurheartj/sux010. Epub 2017 May 2.

12.

Decomposing the Site Frequency Spectrum: The Impact of Tree Topology on Neutrality Tests.

Ferretti L, Ledda A, Wiehe T, Achaz G, Ramos-Onsins SE.

Genetics. 2017 Sep;207(1):229-240. doi: 10.1534/genetics.116.188763. Epub 2017 Jul 5.

PMID:
28679545
13.

Safe fluoroquinolones prophylaxis in blood cancer patients with chemotherapy-induced neutropenia and Glucose-6-Phosphate-Dehydrogenase deficiency.

Sanna M, Caocci G, Orrù F, Ledda A, Vacca A, Piras E, Fozza C, Deias P, Tidore G, Dore F, La Nasa G.

J Clin Pharm Ther. 2017 Dec;42(6):733-737. doi: 10.1111/jcpt.12571. Epub 2017 Jun 8.

PMID:
28597476
14.

Glucose-6-phosphate dehydrogenase deficiency and risk of invasive fungal disease in patients with acute myeloid leukemia.

Sanna M, Caocci G, Ledda A, Orrù F, Fozza C, Deias P, Tidore G, Dore F, La Nasa G.

Leuk Lymphoma. 2017 Nov;58(11):2558-2564. doi: 10.1080/10428194.2017.1312666. Epub 2017 Apr 12.

PMID:
28402154
15.

Highly standardized cranberry extract supplementation (Anthocran®) as prophylaxis in young healthy subjects with recurrent urinary tract infections.

Ledda A, Belcaro G, Dugall M, Riva A, Togni S, Eggenhoffner R, Giacomelli L.

Eur Rev Med Pharmacol Sci. 2017 Jan;21(2):389-393.

16.

Normalization of cardiovascular risk factors in peri-menopausal women with Pycnogenol®.

Luzzi R, Belcaro G, Hosoi M, Feragalli B, Cornelli U, Dugall M, Ledda A.

Minerva Ginecol. 2017 Feb;69(1):29-34. doi: 10.23736/S0026-4784.16.03913-7.

PMID:
28116886
17.

Re-emergence of methicillin susceptibility in a resistant lineage of Staphylococcus aureus.

Ledda A, Price JR, Cole K, Llewelyn MJ, Kearns AM, Crook DW, Paul J, Didelot X.

J Antimicrob Chemother. 2017 May 1;72(5):1285-1288. doi: 10.1093/jac/dkw570.

18.
19.

A novel lecithin based delivery form of Boswellic acids (Casperome®) for the management of osteo-muscular pain: a registry study in young rugby players.

Franceschi F, Togni S, Belcaro G, Dugall M, Luzzi R, Ledda A, Pellegrini L, Eggenhoffner R, Giacomelli L.

Eur Rev Med Pharmacol Sci. 2016 Oct;20(19):4156-4161.

20.

Data related to inflammation and cholesterol deposition triggered by macrophages exposition to modified LDL.

Toledo J, Esteve M, Grasa M, Ledda A, Garda H, Gulfo J, Ludovico ID, Ramella N, Gonzalez M.

Data Brief. 2016 May 27;8:251-7. doi: 10.1016/j.dib.2016.05.046. eCollection 2016 Sep.

21.

Altered lipid partitioning and glucocorticoid availability in CBG-deficient male mice with diet-induced obesity.

Gulfo J, Ledda A, Serra E, Cabot C, Esteve M, Grasa M.

Obesity (Silver Spring). 2016 Aug;24(8):1677-86. doi: 10.1002/oby.21543. Epub 2016 Jun 21.

22.

[ANMCO/SIC/SICI-GISE/SICCH Consensus document: Clinical approach to pharmacological pretreatment for patients undergoing myocardial revascularization].

Caporale R, Geraci G, Gulizia MM, Borzi M, Colivicchi F, Menozzi A, Musumeci G, Scherillo M, Ledda A, Tarantini G, Gerometta P, Casolo G, Formigli D, Romeo F, Di Bartolomeo R; ANMCO/SIC/SICI-GISE/SICCH:.

G Ital Cardiol (Rome). 2016 Jun;17(6):462-90. doi: 10.1714/2262.24352. Italian.

PMID:
27311089
23.

Decreased OxLDL uptake and cholesterol efflux in THP1 cells elicited by cortisol and by cortisone through 11β-hydroxysteroid dehydrogenase type 1.

Ledda A, González M, Gulfo J, Díaz Ludovico I, Ramella N, Toledo J, Garda H, Grasa M, Esteve M.

Atherosclerosis. 2016 Jul;250:84-94. doi: 10.1016/j.atherosclerosis.2016.04.020. Epub 2016 Apr 28.

PMID:
27187933
24.

New Roles for Corticosteroid Binding Globulin and Opposite Expression Profiles in Lung and Liver.

Gulfo J, Ledda A, Gea-Sorlí S, Bonjoch L, Closa D, Grasa M, Esteve M.

PLoS One. 2016 Jan 7;11(1):e0146497. doi: 10.1371/journal.pone.0146497. eCollection 2016.

25.

Triplet vs doublet lenalidomide-containing regimens for the treatment of elderly patients with newly diagnosed multiple myeloma.

Magarotto V, Bringhen S, Offidani M, Benevolo G, Patriarca F, Mina R, Falcone AP, De Paoli L, Pietrantuono G, Gentili S, Musolino C, Giuliani N, Bernardini A, Conticello C, Pulini S, Ciccone G, Maisnar V, Ruggeri M, Zambello R, Guglielmelli T, Ledda A, Liberati AM, Montefusco V, Hajek R, Boccadoro M, Palumbo A.

Blood. 2016 Mar 3;127(9):1102-8. doi: 10.1182/blood-2015-08-662627. Epub 2016 Jan 4. Erratum in: Blood. 2018 Mar 29;131(13):1495.

26.

Pycnogenol® and Centella asiatica to prevent asymptomatic atherosclerosis progression in clinical events.

Belcaro G, Dugall M, Ippolito E, Hosoi M, Cornelli U, Ledda A, Scoccianti M, Cesarone MR, Pellegrini L, Luzzi R, Corsi M, Feragalli B.

Minerva Cardioangiol. 2017 Feb;65(1):24-31. doi: 10.23736/S0026-4725.16.04008-1. Epub 2015 Oct 27.

PMID:
26505327
27.

Miraqule-C and mild heart failure: an 8-week registry.

Belcaro G, Dugall M, Hu S, Corsi M, Hosoi M, Luzzi R, Ippolito E, Feragalli B, Ledda A.

Minerva Gastroenterol Dietol. 2015 Oct 22. [Epub ahead of print]

PMID:
26492589
28.

Supplementary management of benign prostatic hypertrophy with Prostaquil. An 8-week registry.

Belcaro G, Dugall M, Luzzi R, Ledda A, Pellegrini L, Hosoi M, Errichi BM, Francis S, Cornelli U.

Minerva Gastroenterol Dietol. 2015 Oct 22. [Epub ahead of print]

PMID:
26492588
29.

Management of osteoarthritis (OA) with the pharma-standard supplement FlexiQule (Boswellia): a 12-week registry.

Belcaro G, Dugall M, Luzzi R, Ledda A, Pellegrini L, Hu S, Ippolito E.

Minerva Gastroenterol Dietol. 2015 Oct 22. [Epub ahead of print]

PMID:
26492586
30.

Liverubin (standardized silymarin) in the supplementary management of functional, temporary hepatic damage. A pilot, registry, study.

Belcaro G, Hu S, Gizzi G, Corsi M, Dugall M, Hu S, Pellegrini L, Ledda A, Cornelli U, Cesarone MR, Hosoi M, Luzzi R.

Minerva Med. 2014 Dec;105(6 Suppl 2):17-25.

PMID:
26076377
31.

FlexiQule (Boswellia extract) in the supplementary management of osteoarthritis: a supplement registry.

Belcaro G, Dugall M, Luzzi R, Ledda A, Pellegrini L, Cesarone MR, Hosoi M, Errichi M, Francis S, Cornelli U.

Minerva Med. 2014 Dec;105(6 Suppl 2):9-16.

PMID:
26076376
32.

Recurrence of retinal vein thrombosis with Pycnogenol® or Aspirin® supplementation: a registry study.

Rodriguez P, Belcaro G, Dugall M, Hu S, Luzzi R, Ledda A, Ippolito E, Corsi M, Ricci A, Feragalli B, Cornelli U, Gizzi C, Hosoi M.

Panminerva Med. 2015 Sep;57(3):121-5.

PMID:
25971329
33.

Is the use of risk scores an indicator of guideline adherence for patients with acute coronary syndromes? Insights from the EYESHOT Registry.

De Luca L, Leonardi S, Tubaro M, Gonzini L, Lucci D, Trimarco B, Misuraca G, Ledda A, Gulizia MM, De Servi S; EYESHOT Investigators.

Int J Cardiol. 2015;187:80-3. doi: 10.1016/j.ijcard.2015.03.343. Epub 2015 Mar 24. No abstract available.

PMID:
25828318
34.

French Oak Wood (Quercus robur) Extract (Robuvit) in Primary Lymphedema: A Supplement, Pilot, Registry Evaluation.

Belcaro G, Dugall M, Hu S, Ledda A, Ippolito E.

Int J Angiol. 2015 Mar;24(1):47-54. doi: 10.1055/s-0034-1395982.

35.

Cranberry supplementation in the prevention of non-severe lower urinary tract infections: a pilot study.

Ledda A, Bottari A, Luzzi R, Belcaro G, Hu S, Dugall M, Hosoi M, Ippolito E, Corsi M, Gizzi G, Morazzoni P, Riva A, Giacomelli L, Togni S.

Eur Rev Med Pharmacol Sci. 2015 Jan;19(1):77-80.

36.

Meriva®+Glucosamine versus Condroitin+Glucosamine in patients with knee osteoarthritis: an observational study.

Belcaro G, Dugall M, Luzzi R, Ledda A, Pellegrini L, Cesarone MR, Hosoi M, Errichi M.

Eur Rev Med Pharmacol Sci. 2014;18(24):3959-63.

37.

Pycnogenol® and Centella asiatica in the management of asymptomatic atherosclerosis progression.

Belcaro G, Ippolito E, Dugall M, Hosoi M, Cornelli U, Ledda A, Scoccianti M, Steigerwalt RD, Cesarone MR, Pellegrini L, Luzzi R, Corsi M.

Int Angiol. 2015 Apr;34(2):150-7. Epub 2014 Dec 18.

PMID:
25519846
38.

Robuvit® (Quercus robur extract) supplementation in subjects with chronic fatigue syndrome and increased oxidative stress. A pilot registry study.

Belcaro G, Cornelli U, Luzzi R, Ledda A, Cacchio M, Saggino A, Cesarone MR, Dugall M, Feragalli B, Hu S, Pellegrini L, Ippolito E.

J Neurosurg Sci. 2015 Jun;59(2):105-17. Epub 2014 Nov 14.

PMID:
25394351
39.

Toxicity of nanoparticles.

Zoroddu MA, Medici S, Ledda A, Nurchi VM, Lachowicz JI, Peana M.

Curr Med Chem. 2014;21(33):3837-53. Review.

PMID:
25306903
40.

The conserved nhaAR operon is drastically divergent between B2 and non-B2 Escherichia coli and is involved in extra-intestinal virulence.

Lescat M, Reibel F, Pintard C, Dion S, Glodt J, Gateau C, Launay A, Ledda A, Cruveiller S, Tourret J, Tenaillon O.

PLoS One. 2014 Sep 30;9(9):e108738. doi: 10.1371/journal.pone.0108738. eCollection 2014. Erratum in: PLoS One. 2015;10(3):e0118729. Cruvellier, Stephane [corrected to Cruveiller, Stephane].

41.

Robust arm and hand tracking by unsupervised context learning.

Spruyt V, Ledda A, Philips W.

Sensors (Basel). 2014 Jul 7;14(7):12023-58. doi: 10.3390/s140712023.

42.

Interaction of Cu(II) and Ni(II) with Ypk9 protein fragment via NMR studies.

Peana MF, Medici S, Ledda A, Nurchi VM, Zoroddu MA.

ScientificWorldJournal. 2014 Mar 24;2014:656201. doi: 10.1155/2014/656201. eCollection 2014.

43.

The efficacy of sulodexide in the prevention of postthrombotic syndrome.

Luzzi R, Belcaro G, Dugall M, Hu S, Arpaia G, Ledda A, Ippolito E, Corsi M, Ricci A, Cotellese R, Agus G, Errichi BM, Cornelli U, Cesarone MR, Hosoi M.

Clin Appl Thromb Hemost. 2014 Sep;20(6):594-9. doi: 10.1177/1076029614533143. Epub 2014 Apr 29.

PMID:
24781035
44.

Pycnogenol® in postpartum symptomatic hemorrhoids.

Belcaro G, Gizzi G, Pellegrini L, Dugall M, Luzzi R, Corsi M, Ippolito E, Ricci A, Cesarone MR, Ledda A, Bottari A, Errichi BM.

Minerva Ginecol. 2014 Feb;66(1):77-84.

PMID:
24569406
45.

Pycnogenol® and Centella Asiatica for asymptomatic atherosclerosis progression.

Belcaro G, Dugall M, Hosoi M, Ippolito E, Cesarone M, Luzzi R, Cornelli U, Ledda A.

Int Angiol. 2014 Feb;33(1):20-6.

PMID:
24452082
46.

Genomic analysis of therapy-related acute promyelocytic leukemias arising after malignant and non-malignant disorders.

Ottone T, Hasan SK, Voso MT, Ledda A, Montefusco E, Fenu S, Pagoni M, Hubmann M, Lunghi M, Platzbecker U, Lo-Coco F.

Am J Hematol. 2014 Mar;89(3):346-7. doi: 10.1002/ajh.23646. No abstract available.

47.

Greenselect phytosome for borderline metabolic syndrome.

Belcaro G, Ledda A, Hu S, Cesarone MR, Feragalli B, Dugall M.

Evid Based Complement Alternat Med. 2013;2013:869061. doi: 10.1155/2013/869061. Epub 2013 Nov 14.

48.

Efficacy and tolerability of bendamustine, bortezomib and dexamethasone in patients with relapsed-refractory multiple myeloma: a phase II study.

Offidani M, Corvatta L, Maracci L, Liberati AM, Ballanti S, Attolico I, Caraffa P, Alesiani F, Caravita di Toritto T, Gentili S, Tosi P, Brunori M, Derudas D, Ledda A, Gozzetti A, Cellini C, Malerba L, Mele A, Andriani A, Galimberti S, Mondello P, Pulini S, Coppetelli U, Fraticelli P, Olivieri A, Leoni P.

Blood Cancer J. 2013 Nov 22;3:e162. doi: 10.1038/bcj.2013.58.

49.

Evaluation of the effects of supplementation with Pycnogenol® on fitness in normal subjects with the Army Physical Fitness Test and in performances of athletes in the 100-minute triathlon.

Vinciguerra G, Belcaro G, Bonanni E, Cesarone MR, Rotondi V, Ledda A, Hosoi M, Dugall M, Cacchio M, Cornelli U.

J Sports Med Phys Fitness. 2013 Dec;53(6):644-54.

PMID:
24247188
50.

Grape seed procyanidins in pre- and mild hypertension: a registry study.

Belcaro G, Ledda A, Hu S, Cesarone MR, Feragalli B, Dugall M.

Evid Based Complement Alternat Med. 2013;2013:313142. doi: 10.1155/2013/313142. Epub 2013 Sep 19.

Supplemental Content

Support Center